Airi Sasaki

Author Correction Open Access Published: 14 June 2021 Scientific Reports volume 11, Article number: 12857 (2021) Cite this article The Original Article was published on 14 January 2020 Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-57088-1, published online 14 January 2020 The Supplementary Information file published with this Article contained an error, where the Supplementary Tables 1 and 2 were omitted. The original Supplementary Information file is provided below.

Abstract Preventing rejection is a major challenge in transplantation medicine, even when using pluripotent stem cell-derived grafts. In iPS cell (iPSC)-based transplantation, to reduce the risk of rejection, it is thought to be optimal that preparing the cells from donors whose human leukocyte antigen-haplotype are homozygous. Generally, this approach is referred to as major histocompatibility complex (MHC) homo-to-hetero transplantation, which is MHC-matched but minor antigen-mismatched.